Searchable abstracts of presentations at key conferences in endocrinology

ea0029p1107 | Neuroendocrinology | ICEECE2012

The Tuebingen Cushing's disease quality of life inventory: development and normative data from 1784 healthy people

Psaras T. , Honegger J. , Milian M.

Objective: In part I of the study a health related quality of life (HRQoL) inventory for Cushing’s disease (CD), the Tuebingen Cushing-25 quality of life inventory (Tuebingen CD-25) was developed. In the second part, we assessed normative data from healthy controls (HC) with which the individual patients’ scores can be compared.Methods: Sources for item generation consisted of technical literature, interviews with patients and the rating of neu...

ea0029p1205 | Obesity | ICEECE2012

Metabolic and hormonal consequences of circadian rhythm disruption in Bmal1 null mice

Kennaway D. , Boden M. , Varcoe T.

There is compelling evidence that shiftworkers are at risk of developing metabolic disturbances, diabetes and obesity as a result of disruption to circadian rhythms, but the mechanisms by which this may occur are not clear. The Bmal1 null mouse, which lacks both central and peripheral tissue rhythms, was used in this study to address the role of circadian rhythmicity in metabolic homeostasis.Male Bmal1 null mice and wild-type litter mates (2 month...

ea0029p1422 | Pituitary Clinical | ICEECE2012

Body composition has a higher impact on peak GH during the pyridostigmine–GHRH test than the insulin tolerance test in healthy individuals

Eriksen T. , Klose M. , Feldt-Rasmussen U.

Objective: To evaluate the association between body-composition and peak GH, during two standard GH stimulation tests; the pyridostigmine-GHRH (PDGHRH) test and an insulin tolerance test (ITT).Method: 83 healthy subjects (56 men), aged 18–65 years with a median BMI of 24 kg/m2 (range 17–35) underwent a PDGHRH test and an ITT in random order 1 week to 1 month apart. Women had both tests performed in the same phase of their menstrual c...

ea0029p1675 | Thyroid (non-cancer) | ICEECE2012

Measurement of TSH, FT4 and FT3 with immunoassays based on LOCI technology

Lepoutre T. , Daumerie C. , Gruson D.

Background: Measurements of TSH, free tetraiodothyronin (FT4) and triiodothyronin (FT3) are essential to achieve assessment of thyroid function. Luminescent Oxygen Channelling Immunoassays (LOCI) have recently been developed for the measurement of biomarkers of thyroid function. Such homogeneous immunoassays allow a faster delivery of the results. The aim of our study were therefore to determine the reference values for LOCI TSH, FT4 and FT<sub...

ea0029p1715 | Thyroid (non-cancer) | ICEECE2012

Study thyroid function in patients with acromegaly

Shestakova T. , Dreval A. , Ilovaiskaja I. , Zaharevich E.

Goal: Study thyroid function in patients with acromegaly. Materials and method: 88 patients with acromegaly, age 54.6±13.2 years, mediana diagnosis acromegaly 4 years, IGF1 528 (265; 701.3 ng/ml, HG 10.4 (3.7; 30.1) μE/ml, only 12 patients had a remission of disease. All patients were taken TSH, fT4, TPO antibodies, revealed anamnesis of thyroid diseases.Results: 19 from 88 patients (21.6%) had hypothyreosis and 2 (2.3%) had subclini...

ea0029p1826 | Thyroid cancer | ICEECE2012

Cytological thyroid: comparison (intra and interobserver) of results issued by pathologists with different skills of experience

Carvalho N. , Zocratto O. , Rodrigues A. , Nascimento T.

The wide variability of analysis obtained from the fine needle aspiration cytology (FNAC) of thyroid nodules is attributed to experience differences in their interpretation. It is known that reproducibility is a critical parameter for the clinical usefulness of a diagnostic test. However, interobserver and intraobserver reproducibility of cytological examinations of the thyroid has been very little investigated. We studied 74 patients who underwent FNAC and a thyroidectomy. Th...

ea0029p1837 | Thyroid cancer | ICEECE2012

A novel tandem germline RET mutations on the same allele in a patient with MEN 2B

Nakao K. , Usui T. , Ikeda M. , Mori Y. , Kawashima S. , Nanba K. , Tamanaha T. , Tagami T. , Naruse M. , Yamamoto T. , Shimatsu A.

Multiple endocrine neoplasia type2 (MEN 2) (OMIM 171400) is an autosomal dominant inherited cancer syndrome caused by activating mutations in the RET proto-oncogene. MEN 2 is classified into three subtypes: MEN 2A, MEN 2B and familial medullary thyroid carcinoma(FMTC). MEN 2B accounts for 5–10% of MEN2 cases. More than 95% of MEN 2B patients carry M918T mutation of RET, and 2–3% harbor A883F mutation. There has been three reports of cases with MEN 2B phenotype caused...

ea0026p14 | Adrenal cortex | ECE2011

Autosomal recessive pseudohypoaldosteronism: a rare cause of life-threatening electrolyte imbalance

Tharian K , Warner J T , Gregory J

A well-term baby born to consanguineous healthy Yemenese parents was observed in the hospital as parents had lost previous three babies (both male and female) within 10 days of age (in Yemen). These babies who were initially well were reported to have developed a rash and then collapsed and died. Post-mortems were not done. This baby who appeared well at birth, also developed a facial rash on day seven and was found to have hyponatremia and severe hyperkalemia, albeit a normal...

ea0026p62 | Endocrine tumours and neoplasia | ECE2011

Injection systems for long-acting somatostatin analogs: a comparative assessment of preparation times and nurses' perceptions

Adelman D T , Burgess A , Davies P R

Introduction: The two major long-acting somatostatin analogues (SSA) available on the European market for the treatment of neuroendocrine tumours and acromegaly are Somatuline Autogel (SA) and Sandostatin LAR (LAR). The aim of this study was to gain nurses’ insights on the use and ease of administration of SSA devices, including Somatuline Autogel new device (SA-ND), in Europe and the US.Methods/design: Seventy-seven qualified nurses with ≥3 S...

ea0026p411 | Thyroid (non cancer) | ECE2011

Thyroid peroxidase antibodies in euthyroid children: is long term follow up required?

Tharian K , Evans C , Warner J T

Introduction: The presence of thyroid peroxidase (TPO) antibodies in euthyroid children poses a potential risk for the development of autoimmune hypothyroidism. Little is known about the ontogeny of this process. This retrospective study aims to estimate the risk of developing hypothyroidism in euthyroid children with raised TPO antibodies and provide a guideline for follow up.Methods: Children 0–16 years with raised TPO antibodies (1996–2005) ...